Fluzone Quadrivalent
AssetAlso Fluzone Quadrivalent vaccine, 2015-2016 formulation, No Preservative, Fluzone Quadrivalent vaccine, 2016-2017 formulation, No Preservative, High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northern Hemisphere formulation, Inactivated, split-virion, influenza vaccine
Inactivated split-virion quadrivalent influenza vaccine inducing protective humoral immune responses against influenza strains.
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Not known
- 5
- Indications
- 89
- Trials
- 1
- Developer
Indications
5Influenza
Phase 3, Completed, NCT02908269, clinicaltrials.gov, 7 Oct 2026
Influenza immunization
Phase 3, Completed, NCT04024228, clinicaltrials.gov, 7 Oct 2026
Multiple sclerosis
Phase 2, Completed, NCT01403376, clinicaltrials.gov, 8 Oct 2026
2 more
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials89
- Evidence for its targets1
- Competitors4
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 8 Oct 2026, 5 sources